Novel Approaches to the Diagnosis, Prevention, and Treatment of Medical Device-Associated Infections

Infectious Disease Clinics of North America

Volumn 26, Issue 1, 2012, Pages 173-186

  Vergidis, Paschalis ^a   Patel, Robin ^a  

^a MAYO CLINIC   (United States)

Author keywords

Biofilm; Cardiovascular implantable electronic device infection; Catheter associated bloodstream infection; Catheter associated urinary tract infection; Medical device; Orthopedic implant infection

Indexed keywords

ANTIBIOTIC AGENT; CHLORHEXIDINE; CLINDAMYCIN; DAPTOMYCIN; ERYTHROMYCIN; GENTAMICIN; MINOCYCLINE; NITROFURAL; RIFAMPICIN; SILVER; VANCOMYCIN;

ANTIBIOSIS; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ASYMPTOMATIC BACTERIURIA; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIAL VIABILITY; BIOFILM; CARDIOVASCULAR EQUIPMENT; CATHETER INFECTION; CATHETER REMOVAL; DEVICE INFECTION; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DRUG EFFECT; ELECTRONICS; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; MATERIAL COATING; MEDICAL DEVICE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; ORTHOPEDIC PROSTHESIS; QUORUM SENSING; REVIEW; TREATMENT PLANNING; URINARY TRACT INFECTION;

BACTEREMIA; BIOFILMS; CATHETERIZATION; HUMANS; PROSTHESES AND IMPLANTS; PROSTHESIS-RELATED INFECTIONS; URINARY TRACT INFECTIONS;

EID: 84856258205     PISSN: 08915520     EISSN: 15579824     Source Type: Journal    
DOI: 10.1016/j.idc.2011.09.012     Document Type: Review

References (76)

1. del Pozo J.L., Patel R. The challenge of treating biofilm-associated bacterial infections. Clin Pharmacol Ther 2007, 82(2):204-209.
2. Costerton W.J., Montanaro L., Balaban N., et al. Prospecting gene therapy of implant infections. Int J Artif Organs 2009, 32(9):689-695.
3. Speziale P., Pietrocola G., Rindi S., et al. Structural and functional role of Staphylococcus aureus surface components recognizing adhesive matrix molecules of the host. Future Microbiol 2009, 4(10):1337-1352.
4. O'Gara J.P. ica and beyond: biofilm mechanisms and regulation in Staphylococcus epidermidis and Staphylococcus aureus. FEMS Microbiol Lett 2007, 270(2):179-188.
5. Balaban N., Stoodley P., Fux C.A., et al. Prevention of staphylococcal biofilm-associated infections by the quorum sensing inhibitor RIP. Clin Orthop Relat Res 2005, 437:48-54.
6. Kiran M.D., Balaban N. TRAP plays a role in stress response in Staphylococcus aureus. Int J Artif Organs 2009, 32(9):592-599.
7. Anguita-Alonso P., Giacometti A., Cirioni O., et al. RNAIII-inhibiting-peptide-loaded polymethylmethacrylate prevents invivo Staphylococcus aureus biofilm formation. Antimicrob Agents Chemother 2007, 51(7):2594-2596.
8. Balaban N., Cirioni O., Giacometti A., et al. Treatment of Staphylococcus aureus biofilm infection by the quorum-sensing inhibitor RIP. Antimicrob Agents Chemother 2007, 51(6):2226-2229.
9. Cirioni O., Ghiselli R., Minardi D., et al. RNAIII-inhibiting peptide affects biofilm formation in a rat model of staphylococcal ureteral stent infection. Antimicrob Agents Chemother 2007, 51(12):4518-4520.
10. Donlan R.M. Preventing biofilms of clinically relevant organisms using bacteriophage. Trends Microbiol 2009, 17(2):66-72.
11. Cerca N., Oliveira R., Azeredo J. Susceptibility of Staphylococcus epidermidis planktonic cells and biofilms to the lytic action of staphylococcus bacteriophage K. Lett Appl Microbiol 2007, 45(3):313-317.
12. Sharma M., Ryu J.H., Beuchat L.R. Inactivation of Escherichia coli O157:H7 in biofilm on stainless steel by treatment with an alkaline cleaner and a bacteriophage. JAppl Microbiol 2005, 99(3):449-459.
13. Lu T.K., Collins J.J. Dispersing biofilms with engineered enzymatic bacteriophage. Proc Natl Acad Sci USA 2007, 104(27):11197-11202.
14. Curtin J.J., Donlan R.M. Using bacteriophages to reduce formation of catheter-associated biofilms by Staphylococcus epidermidis. Antimicrob Agents Chemother 2006, 50(4):1268-1275.
15. Fu W., Forster T., Mayer O., et al. Bacteriophage cocktail for the prevention of biofilm formation by Pseudomonas aeruginosa on catheters in an invitro model system. Antimicrob Agents Chemother 2010, 54(1):397-404.
16. Del Pozo J.L., Rouse M.S., Patel R. Bioelectric effect and bacterial biofilms. A systematic review. Int J Artif Organs 2008, 31(9):786-795.
17. del Pozo J.L., Rouse M.S., Mandrekar J.N., et al. Effect of electrical current on the activities of antimicrobial agents against Pseudomonas aeruginosa, Staphylococcus aureus, and Staphylococcus epidermidis biofilms. Antimicrob Agents Chemother 2009, 53(1):35-40.
18. del Pozo J.L., Rouse M.S., Mandrekar J.N., et al. The electricidal effect: reduction of Staphylococcus and Pseudomonas biofilms by prolonged exposure to low-intensity electrical current. Antimicrob Agents Chemother 2009, 53(1):41-45.
19. Del Pozo J.L., Rouse M.S., Euba G., et al. The electricidal effect is active in an experimental model of Staphylococcus epidermidis chronic foreign body osteomyelitis. Antimicrob Agents Chemother 2009, 53(10):4064-4068.
20. Qian Z., Sagers R.D., Pitt W.G. The effect of ultrasonic frequency upon enhanced killing of P. aeruginosa biofilms. Ann Biomed Eng 1997, 25(1):69-76.
21. Rediske A.M., Roeder B.L., Nelson J.L., et al. Pulsed ultrasound enhances the killing of Escherichia coli biofilms by aminoglycoside antibiotics invivo. Antimicrob Agents Chemother 2000, 44(3):771-772.
22. Carmen J.C., Nelson J.L., Beckstead B.L., et al. Ultrasonic-enhanced gentamicin transport through colony biofilms of Pseudomonas aeruginosa and Escherichia coli. JInfect Chemother 2004, 10(4):193-199.
23. Runyan C.M., Carmen J.C., Beckstead B.L., et al. Low-frequency ultrasound increases outer membrane permeability of Pseudomonas aeruginosa. JGen Appl Microbiol 2006, 52(5):295-301.
24. Bigelow T.A., Northagen T., Hill T.M., et al. The destruction of Escherichia coli biofilms using high-intensity focused ultrasound. Ultrasound Med Biol 2009, 35(6):1026-1031.
25. Ensing G.T., Neut D., van Horn J.R., et al. The combination of ultrasound with antibiotics released from bone cement decreases the viability of planktonic and biofilm bacteria: An invitro study with clinical strains. JAntimicrob Chemother 2006, 58(6):1287-1290.
26. Ensing G.T., Roeder B.L., Nelson J.L., et al. Effect of pulsed ultrasound in combination with gentamicin on bacterial viability in biofilms on bone cements invivo. JAppl Microbiol 2005, 99(3):443-448.
27. Ahearn D.G., Grace D.T., Jennings M.J., et al. Effects of hydrogel/silver coatings on invitro adhesion to catheters of bacteria associated with urinary tract infections. Curr Microbiol 2000, 41(2):120-125.
28. Davenport K., Keeley F.X. Evidence for the use of silver-alloy-coated urethral catheters. JHosp Infect 2005, 60(4):298-303.
29. Schumm K., Lam T.B. Types of urethral catheters for management of short-term voiding problems in hospitalised adults. Cochrane Database Syst Rev 2008, 2. CD004013.
30. Drekonja D.M., Kuskowski M.A., Wilt T.J., et al. Antimicrobial urinary catheters: a systematic review. Expert Rev Med Devices 2008, 5(4):495-506.
31. Trautner B.W., Hull R.A., Darouiche R.O. Escherichia coli 83972 inhibits catheter adherence by a broad spectrum of uropathogens. Urology 2003, 61(5):1059-1062.
32. Darouiche R.O., Thornby J.I., Cerra-Stewart C., et al. Bacterial interference for prevention of urinary tract infection: A prospective, randomized, placebo-controlled, double-blind pilot trial. Clin Infect Dis 2005, 41(10):1531-1534.
33. Sherertz R.J., Raad I.I., Belani A., et al. Three-year experience with sonicated vascular catheter cultures in a clinical microbiology laboratory. JClin Microbiol 1990, 28(1):76-82.
34. Bouza E., Alvarado N., Alcala L., et al. Aprospective, randomized, and comparative study of 3 different methods for the diagnosis of intravascular catheter colonization. Clin Infect Dis 2005, 40(8):1096-1100.
35. Slobbe L., El Barzouhi A., Boersma E., et al. Comparison of the roll plate method to the sonication method to diagnose catheter colonization and bacteremia in patients with long-term tunnelled catheters: a randomized prospective study. JClin Microbiol 2009, 47(4):885-888.
36. Safdar N., Fine J.P., Maki D.G. Meta-analysis: methods for diagnosing intravascular device-related bloodstream infection. Ann Intern Med 2005, 142(6):451-466.
37. Raad I., Hanna H.A., Alakech B., et al. Differential time to positivity: a useful method for diagnosing catheter-related bloodstream infections. Ann Intern Med 2004, 140(1):18-25.
38. Guembe M., Rodriguez-Creixems M., Sanchez-Carrillo C., et al. How many lumens should be cultured in the conservative diagnosis of catheter-related bloodstream infections?. Clin Infect Dis 2010, 50(12):1575-1579.
39. O'Grady N.P., Alexander M., Burns L.A., et al. Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 2011, 52(9):e162-e193.
40. Casey A.L., Mermel L.A., Nightingale P., et al. Antimicrobial central venous catheters in adults: a systematic review and meta-analysis. Lancet Infect Dis 2008, 8(12):763-776.
41. Brun-Buisson C., Doyon F., Sollet J.P., et al. Prevention of intravascular catheter-related infection with newer chlorhexidine-silver sulfadiazine-coated catheters: a randomized controlled trial. Intensive Care Med 2004, 30(5):837-843.
42. Ostendorf T., Meinhold A., Harter C., et al. Chlorhexidine and silver-sulfadiazine coated central venous catheters in haematological patients-a double-blind, randomised, prospective, controlled trial. Support Care Cancer 2005, 13(12):993-1000.
43. Rupp M.E., Lisco S.J., Lipsett P.A., et al. Effect of a second-generation venous catheter impregnated with chlorhexidine and silver sulfadiazine on central catheter-related infections: a randomized, controlled trial. Ann Intern Med 2005, 143(8):570-580.
44. Corral L., Nolla-Salas M., Ibanez-Nolla J., et al. Aprospective, randomized study in critically ill patients using the Oligon Vantex catheter. JHosp Infect 2003, 55(3):212-219.
45. Hagau N., Studnicska D., Gavrus R.L., et al. Central venous catheter colonization and catheter-related bloodstream infections in critically ill patients: a comparison between standard and silver-integrated catheters. Eur J Anaesthesiol 2009, 26(9):752-758.
46. Bong J.J., Kite P., Wilco M.H., et al. Prevention of catheter related bloodstream infection by silver iontophoretic central venous catheters: a randomised controlled trial. JClin Pathol 2003, 56(10):731-735.
47. Darouiche R.O., Raad I.I., Heard S.O., et al. Acomparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group. NEngl J Med 1999, 340(1):1-8.
48. Hanna H., Benjamin R., Chatzinikolaou I., et al. Long-term silicone central venous catheters impregnated with minocycline and rifampin decrease rates of catheter-related bloodstream infection in cancer patients: a prospective randomized clinical trial. JClin Oncol 2004, 22(15):3163-3171.
49. Yahav D., Rozen-Zvi B., Gafter-Gvili A., et al. Antimicrobial lock solutions for the prevention of infections associated with intravascular catheters in patients undergoing hemodialysis: systematic review and meta-analysis of randomized, controlled trials. Clin Infect Dis 2008, 47(1):83-93.
50. Henrickson K.J., Axtell R.A., Hoover S.M., et al. Prevention of central venous catheter-related infections and thrombotic events in immunocompromised children by the use of vancomycin/ciprofloxacin/heparin flush solution: a randomized, multicenter, double-blind trial. JClin Oncol 2000, 18(6):1269-1278.
51. Sanders J., Pithie A., Ganly P., et al. Aprospective double-blind randomized trial comparing intraluminal ethanol with heparinized saline for the prevention of catheter-associated bloodstream infection in immunosuppressed haematology patients. JAntimicrob Chemother 2008, 62(4):809-815.
52. Fortun J., Grill F., Martin-Davila P., et al. Treatment of long-term intravascular catheter-related bacteraemia with antibiotic-lock therapy. JAntimicrob Chemother 2006, 58(4):816-821.
53. Atkins B.L., Athanasou N., Deeks J.J., et al. Prospective evaluation of criteria for microbiological diagnosis of prosthetic-joint infection at revision arthroplasty. The OSIRIS Collaborative Study Group. JClin Microbiol 1998, 36(10):2932-2939.
54. Trampuz A., Piper K.E., Jacobson M.J., et al. Sonication of removed hip and knee prostheses for diagnosis of infection. NEngl J Med 2007, 357(7):654-663.
55. Piper K.E., Jacobson M.J., Cofield R.H., et al. Microbiologic diagnosis of prosthetic shoulder infection by use of implant sonication. JClin Microbiol 2009, 47(6):1878-1884.
56. Sampedro M.F., Huddleston P.M., Piper K.E., et al. Abiofilm approach to detect bacteria on removed spinal implants. Spine 2010, 35(12):1218-1224.
57. Vergidis P, Greenwood-Quaintance KE, Sanchez-Sotelo, et al. Implant sonication for the diagnosis of prosthetic elbow infection. J Shoulder Elbow Surg (in press).
58. Dailey A, Nyre L, Piper K, etal. Hip or knee prosthesis sonicate cultures have a shorter time to positivity compared to periprosthetic tissue cultures. 49th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco (CA), September 12-15, 2009.
59. Dora C., Altwegg M., Gerber C., et al. Evaluation of conventional microbiological procedures and molecular genetic techniques for diagnosis of infections in patients with implanted orthopedic devices. JClin Microbiol 2008, 46(2):824-825.
60. Achermann Y., Vogt M., Leunig M., et al. Improved diagnosis of periprosthetic joint infection by multiplex PCR of sonication fluid from removed implants. JClin Microbiol 2010, 48(4):1208-1214.
61. Panousis K., Grigoris P., Butcher I., et al. Poor predictive value of broad-range PCR for the detection of arthroplasty infection in 92 cases. Acta Orthop 2005, 76(3):341-346.
62. Berbari E., Mabry T., Tsaras G., et al. Inflammatory blood laboratory levels as markers of prosthetic joint infection: a systematic review and meta-analysis. JBone Joint Surg Am 2010, 92(11):2102-2109.
63. Artini M., Romano C., Manzoli L., et al. Staphylococcal IgM enzyme-linked immunosorbent assay for diagnosis of periprosthetic joint infections. JClin Microbiol 2011, 49(1):423-425.
64. Deirmengian C., Hallab N., Tarabishy A., et al. Synovial fluid biomarkers for periprosthetic infection. Clin Orthop Relat Res 2010, 468(8):2017-2023.
65. Jacovides C.L., Parvizi J., Adeli B., et al. Molecular markers for diagnosis of periprosthetic joint infection. J Arthroplasty 2011, 26(6 Suppl):99-103.
66. Engesaeter L.B., Lie S.A., Espehaug B., et al. Antibiotic prophylaxis in total hip arthroplasty: effects of antibiotic prophylaxis systemically and in bone cement on the revision rate of 22,170 primary hip replacements followed 0-14 years in the Norwegian Arthroplasty Register. Acta Orthop Scand 2003, 74(6):644-651.
67. Berbari E.F., Osmon D.R., Carr A., et al. Dental procedures as risk factors for prosthetic hip or knee infection: a hospital-based prospective case-control study. Clin Infect Dis 2010, 50(1):8-16.
68. Ehrlich G.D., Stoodley P., Kathju S., et al. Engineering approaches for the detection and control of orthopaedic biofilm infections. Clin Orthop Relat Res 2005, (437):59-66.
69. Dy Chua J., Abdul-Karim A., Mawhorter S., et al. The role of swab and tissue culture in the diagnosis of implantable cardiac device infection. Pacing Clin Electrophysiol 2005, 28(12):1276-1281.
70. Viola G.M., Mansouri M.D., Nasir N., et al. Incubation alone is adequate as a culturing technique for cardiac rhythm management devices. JClin Microbiol 2009, 47(12):4168-4170.
71. Mason P.K., Dimarco J.P., Ferguson J.D., et al. Sonication of explanted cardiac rhythm management devices for the diagnosis of pocket infections and asymptomatic bacterial colonization. Pacing Clin Electrophysiol 2011, 34(2):143-149.
72. Rohacek M., Weisser M., Kobza R., et al. Bacterial colonization and infection of electrophysiological cardiac devices detected with sonication and swab culture. Circulation 2010, 121(15):1691-1697.
73. Pichlmaier M., Marwitz V., Kuhn C., et al. High prevalence of asymptomatic bacterial colonization of rhythm management devices. Europace 2008, 10(9):1067-1072.
74. de Oliveira J.C., Martinelli M., Nishioka S.A., et al. Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators: results of a large, prospective, randomized, double-blinded, placebo-controlled trial. Circ Arrhythm Electrophysiol 2009, 2(1):29-34.
75. Voigt A., Shalaby A., Saba S. Continued rise in rates of cardiovascular implantable electronic device infections in the United States: temporal trends and causative insights. Pacing Clin Electrophysiol 2010, 33(4):414-419.
76. Bloom H.L., Constantin L., Dan D., et al. Implantation success and infection in cardiovascular implantable electronic device procedures utilizing an antibacterial envelope. Pacing Clin Electrophysiol 2011, 34(2):133-142.